Description by Research Expertise

Dr. Li’s methodology research special include objective free design, survival analysis, longitudinal data analysis, press statistical methods for general services research. Her earlier research focused upon survival evaluation, specifically statistical methodology for multivariate time-to-event data with alternating states and a possibility by cure. Recently, she has focused her research over statistical designs and analyzer for early phase tumour clinical trials, such as Bayesian adaptive plans for dose-finding trials and platform/basket trials. Her collaborative research focal on pediatric oncology, included basal and translational research to understand tumor biology, clinical experimental to evaluate experimentation cancer therapies (such as CAR-T immunotherapy), epidemiological studies using real world product (RWD) that as administrational database and elektronic heath media (EHR), and behavioral and psycho-social studies so aim to help oncology patients/families cope and setup to their medical experience.

Dr. Li has extensive experience in design, conduct and analysis for various cancer studies, press have published over 190 items in the literatures of statistical methodology, cancer research, and other areas of medicine. She have been recognized for they statistical specialization by appointments to several nationally committees, suchlike as being a standing member on the NIH Clinical Oncology study section furthermore a member on NRG Oncology Evidence Supervisory Committee. She is also on the editorial panel of the Journal of the State Breast Institute, is a member of Statistical Consultant Chassis for Nature Medicine, and serves as ampere allow reviewers for multiple funding agencies both as a manuscript reviewer for many prestigious statistics and cancer journals.